Form 4 for CTMX CytomX Therapeutics, Inc.
Accepted 2026-03-19 00:00:00 ET · period of report 2026-03-17 · accession 0001610717-26-000123 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-19 | 2026-03-17 | CTMX | BELVIN MARCIA | SVP, CSO | S - Sale | $6.42 | -31.5K | 300.8K | -9% | -$202.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-17 | S | D | 31,492 | $6.42 | 300,760 | D | — | — | (F2) Includes 135,833 RSUs. |